Epinephrine injection - Par Sterile Products
Alternative Names: AdrenalinLatest Information Update: 28 May 2025
At a glance
- Originator JHP Pharmaceuticals
- Developer Par Sterile Products
- Class Anti-infectives; Antiallergics; Antiasthmatics; Bronchodilators; Catecholamines; Ethanolamines; Skin disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaphylaxis; Eye disorders
Most Recent Events
- 15 May 2025 Endo launches a new concentration of ADRENALIN® (epinephrine in 0.9% sodium chloride injection) premixed bag
- 02 Dec 2024 Endo launches ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use epinephrine premixed intravenous (IV) bag
- 31 Dec 2021 Par Sterile Products has patent protection for epinephrine injection till 2035, in the US